Updated Safety and Efficacy Results From the Archway Phase 3 Trial of the Port Delivery System With Ranibizumab (PDS) for Neovascular AMD

Related

• 

  Expert Panel:PDS

  Robert A. Mittra, MD, FASRS

  Dante Joseph Pieramici, MD

  Aleksandra V. Rachitskaya, MD, FASRS

  Margaret A. Chang, MD, MS

  Carl C. Awh, MD, FASRS

  Annual Meeting Talks

  2024

• 

  Prospective Longitudinal Study: Fluid Quantification From Daily Self-imaging With Home OCT in Neovascular Age-Related Macular Degeneration (NV-AMD)

  Jeffrey S. Heier, MD

  Updates from the Field

  2021

• 

  Expert Panel: Faricimab and Aflibercept 8 mg in Diabetic Retinopathy

  Judy E. Kim, MD, FASRS

  Chirag D. Jhaveri, MD, FASRS

  Michael S. Ip, MD

  Arshad M. Khanani, MD, MA, FASRS

  Jordana G Fein, MD, MS

  Dennis M. Marcus, MD

  Diana V Do, MD, FASRS

  Annual Meeting Talks

  2024